We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Extends Type III Drug Master File E-Submission Compliance Date Another Year
FDA Extends Type III Drug Master File E-Submission Compliance Date Another Year
The FDA issued revised guidance on electronic submissions of drug master files, extending the timetable for Type III submissions by another year to May 5, 2020.